Journals / Turkish Journal of Pharmaceutical Sciences / 2018 / Cilt: 15 - Sayı: 2

Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy

Tamsulosin Hidroklorür ve Solifenasin Süksinatın Senkronize Türev Emisyon Spektrometrisi Yöntemiyle Eşzamanlı Miktar Tayinleri

Pages
149–155
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results were well in agreement with their label claim.Conclusion: The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneousquantification of tamsulosin hydrochloride and solifenacin succinate.Materials and Methods: First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes.Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacinsuccinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).Results: Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL forsolifenacin succinate.
📊
Key Findings & Data:The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochlorideand 103.5 for solifenacin succinate by the proposed method.
💡
Conclusion & Impact:These results were well in agreement with their label claim.Conclusion: The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: The present study was undertaken with the objective to develop and validate a simple spectrofluorimetric method for the simultaneousquantification of tamsulosin hydrochloride and solifenacin succinate.Materials and Methods: First-derivative synchronous spectrofluorimetry was attempted for the simultaneous quantification of the analytes.Tamsulosin hydrochloride was quantified at a wavelength of 322 nm (zero-crossing wavelength point of solifenacin succinate) and solifenacinsuccinate was measured at 570 nm (zero-crossing wavelength point of tamsulosin hydrochloride).Results: Calibration plots were constructed over the concentration range of 2-10 µg/mL for tamsulosin hydrochloride and 30-150 µg/mL forsolifenacin succinate. The method gave satisfactory results when it is validated for linearity, specificity, accuracy, precision, LOD and LOQ as perthe ICH guidelines. The assay values in the commercial formulation were found to be in the percentage range of 95.0 for tamsulosin hydrochlorideand 103.5 for solifenacin succinate by the proposed method. These results were well in agreement with their label claim.Conclusion: The proposed synchronous analytical method can be employed for routine quality control analysis of tamsulosin hydrochloride/solifenacin succinate in tablet dose forms.

Özet

Amaç: Bu çalışmanın amacı tamsulosin hidroklorür ve solifenasin süksinatın aynı anda miktar tayininin yapılabilmesi için basit bir senkronize spektroflorimetri yöntemi geliştirmek ve valide etmektir. Gereç ve Yöntemler: Bahsedilen analitlerin aynı anda miktar tayinlerinin yapılabilmesi için birinci türev senkronize spektroflorimetri yöntemi kullanılmıştır. Tamsulosin hidroklorür 322 nm de ölçüm yapılarak (bu dalga boyu solifenasin süksinatın sıfır kesim noktasıdır) solifenasin süksinat ise 570 nm de ölçüm yapılarak (bu dalga boyu tamsulosin hidroklorürün sıfır kesim noktasıdır) miktar tayinleri gerçekleştirilmiştir. Bulgular: Kalibrasyon eğrileri tamsulosin hidroklorür için 2-10 μg/mL, solifenasin süksinat için ise 30-150 μg/mL konsantrasyon aralığında hazırlanmıştır. Geliştirilen yöntemle; ICH kılavuzlarına göre hesaplanan doğrusallık, seçicilik, doğruluk, kesinlik ve LOD ve LOQ değerleri kullanılarak başarılı sonuçlar elde edilmiştir. Önerilen yöntemle yapılan analiz sonuçları ticari formülasyon içerisinde tamsulosin hidroklorürün %95.0 solifenasin süksinatın ise %103.5 oranında bulunduğunu göstermiştir. Bu sonuçlar preparatın üzerinde belirtilen değerler ile iyi bir uygunluk göstermektedir. Sonuç: Önerilen analitik yöntemin tablet dozaj formlarında tamsulosin hidroklorür ve solifenasin süksinatın rutin kontrol analizlerinde kullanılabileceği anlaşılmıştır.

🔖

Cite This Article

NARAPARAJU, S., ANUMOLU, P. K. D., GURRALA, S., GALENNAGARI, R. (2022). Quantification of Tamsulosin Hydrochloride and Solifenacin Succinate by Discriminative Derivative Synchronous Emission Spectroscopy. Turkish Journal of Pharmaceutical Sciences, Cilt: 15 - Sayı: 2, 149–155. https://ajindex.com/articles/613846

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Takenaka T, Fujikura T, Honda K, Asano M, Niigata K. Discovery and development of tamsulosin hydrochloride, a new alpha 1-adrenergic antagonist. Yukugaku Zasshi. 1995;115:773-789
  2. Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y, Hatanaka T, Suzuki M, Sato S, Sasamata M, Miyata K. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biol Pharm Bull. 2007;30:54-58
  3. Dimitropoulos K, Gravas S. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Drug Des Devel Ther. 2015;9:1707- 1716
  4. Raghubabu K, Swarup Shanti L, Kalyanaramu B, Rao MN, Ramdas C. Simple and inexpensive methods development for the estimation of tamsulosin hydrochloride as a single component from its solid dosage forms by Visible spectrophotometry. Int J Pharm Biol Sci. 2012;2:12-19
  5. Shrivastava A, Saxena P, Gupta VB. Spectrophotometric estimation of tamsulosin hydrochloride by acid-dye method. Pharm Methods. 2011;2:53-60
  6. Thimmaraju MK, Rao V, Hemanth K, Siddartha K. Determination of tamsulosin in bulk and pharmaceutical dosage forms by UV spectrophotometric method. J Chem Pharm Res. 2011;3:762-767
  7. Rizka M, Toubara SS, Habibb HI, Mona S, Elshaheda. Stability indicating micelle-enhanced spectrofluorimetric method for determination of tamsulosin hydrochloride in dosage forms. J Adv Chem. 2015;11:3513- 3531
  8. Patel DB, Patel NU, Chaudhari BG. Validated spectrofluorimetric method for the determination of tamsulosin hydrochloride in tablet dosage form. Pelgia Research Library. 2011;2:172-175
  9. Puttagunta SB, Shaik RP, Bannoth CK, Challa BSR, Awen BZS. Bioanalytical method for quantification of solifenacin in rat plasma by LC-MS/MS and its application to pharmacokinetic study. J Anal Sci Technol. 2014;5:35
  10. Rakesh B, Bhargavi P, Reddy SR, Kumar AA. UV-Spectrophotometric method development and validation for the quantitative estimation of solifenacin succinate in tablets. Int J Pharm Pharm Sci. 2014;6:190-193
  11. Seshamamba BSV, Satyanarayana PVV, Sekaran CB. Development and validation of spectrophotometric methods for the quantification of solifenacin succinate application to tablet dosage forms. Int Let. Chem Phy Astr. 2013;15:167-182
  12. Israel DS, Krishnachaitanya K, Sankar DG. RP-HPLC Method for the estimation of tamsulosin and solifenacin in bulk and its dosage forms. Int J Pharm Sci Res.